2022
Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors-single center study
MEDILEK, Karel, Lenka ZALOUDKOVA, Alexander BORG, Lucie KUBÍNOVÁ, Josef STASEK et. al.Základní údaje
Originální název
Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors-single center study
Autoři
MEDILEK, Karel (203 Česká republika, garant), Lenka ZALOUDKOVA (203 Česká republika), Alexander BORG, Lucie KUBÍNOVÁ (203 Česká republika, domácí) a Josef STASEK (203 Česká republika)
Vydání
Echocardiography - A Journal of Cardiovascular Ultrasound and Allied Techniques, HOBOKEN, WILEY, 2022, 0742-2822
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.500
Kód RIV
RIV/00216224:14110/22:00128278
Organizační jednotka
Lékařská fakulta
UT WoS
000838624800001
Klíčová slova anglicky
negative stress echocardiography; myocardial injury; hsTnT
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 25. 1. 2023 14:06, Mgr. Tereza Miškechová
Anotace
V originále
Objectives: In stress echocardiography (SE), dipyridamole (DIP) and dynamic stress (ExSE) are reported as being safer than dobutamine stress echocardiography (DSE). We investigated whether these commonly used stressors cause myocardial injury, measured by high sensitivity troponin T (hsTnT). Methods: One hundred and thirty five patients (DSE n = 46, ExsE n = 46, DIP n = 43) with negative result of SE were studied. The exclusion criteria were known ischaemic heart disease (IHD), baseline wall motion abnormalities, left ventricle systolic dysfunction/regional wall motion abnormalities, septum/posterior wall >= 13 mm, diabetes/pre-diabetes, baseline hsTnT level >= 14 ng/L, baseline blood pressure >= 160/100 mmHg, peak pulmonary pressure >= 45mmHg, eGFR <1ml/s/1.73m(2), more than mild to moderate valvular disease and dobutamine side effects. HsTnT was measured before and 180 minutes after the test. Results: All patients had low pre-test probabilities of having obstructive IHD. HsTnT increased in DSE, less so in ExSE, and was unchanged in the DIP group (Delta hsTnT 9.4 [1.5-58.6], 1.1 [-0.9-15.7], -0.1 [-1.4-2.1] ng/L, respectively, p<0.001). In DSE, the Delta hsTnT was associated with peak dobutamine dose (r = 0.30, p = 0.045), test length (r = 0.43, p = 0.003) and atropine use (p<0.001). In ExSE, the hsTnT increase was more likely in females (p = 0.012) and the elderly (>65 years) (r = 0.32, p = 0.03); no association was found between atropine use (p = 0.786) or test length and AhsTnT (r = 0.10, p = 0.530). Conclusions: DSE is associated with myocardial injury in patients with negative SE, no injury was observed in DIP and only mild case in ExSE. Whether myocardial injury is causative of the higher reported adverse event rates in DSE remains to be determined.